DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

TruAlt Bioenergy Limited — Outcome of Board Meeting

NSE 1 hr ago·23 Oct 2026, 2:18 pm

Trualt Bioenergy

TruAlt Bioenergy Limited has informed the stock exchange that its board has approved the financial results for the period ending September 30, 2026. This filing confirms that the company has completed its internal review and reporting processes for this quarter.

For investors, this update is a standard procedural step that signals the company is maintaining its regulatory compliance. It provides a scheduled opportunity for the market to digest the company's performance metrics and operational progress.

Investors should watch for the detailed release of these financial figures, which will likely be published in the company's official press release. This data will offer deeper insights into the company's revenue, profitability, and future outlook.